Gentamicin is an antibiotic used in dogs to treat bacterial infections of the ears, eyes, skin, respiratory tract, and in serious cases, life-threatening systemic infections like sepsis. It belongs to a class of antibiotics called aminoglycosides and is particularly effective against staphylococci and a broad range of gram-negative bacteria, the types responsible for many stubborn infections in dogs.
Gentamicin comes in several forms: injectable solutions for severe internal infections, nebulized treatments for respiratory disease, and topical creams, drops, or ointments for ears and eyes. The form your vet chooses depends entirely on where the infection is and how serious it has become.
Ear and Eye Infections
The most common reason dogs receive gentamicin is for ear infections. Topical otic (ear) preparations containing gentamicin treat infections of the ear canal, and many veterinary ear products combine gentamicin with an antifungal and a steroid to tackle bacteria, yeast, and inflammation all at once. These are applied directly into the ear canal, typically once or twice daily.
One important precaution with ear use: the eardrum must be intact before treatment begins. The FDA’s guidance for topical ear medications in dogs specifically notes that gentamicin has not been evaluated in dogs with perforated tympanic membranes. If the drug passes through a ruptured eardrum into the middle or inner ear, it can cause hearing loss or vestibular problems (loss of balance, head tilting, disorientation). Your vet will usually examine the eardrum with an otoscope before prescribing these drops.
Gentamicin ophthalmic drops or ointments work the same way for bacterial eye infections, delivering the antibiotic directly to the surface of the eye where it’s needed.
Respiratory Infections
Gentamicin is also used to treat lower airway infections in dogs, particularly those caused by Bordetella bronchiseptica, one of the primary bacteria behind kennel cough and canine infectious respiratory disease complex. In dogs whose infections don’t respond to standard oral antibiotics, gentamicin can be delivered through nebulization, a process where the liquid drug is converted into a fine mist that the dog breathes in.
Research published in the American Journal of Veterinary Research found that a three-minute nebulization of undiluted gentamicin achieved therapeutic concentrations in the lungs while keeping blood levels below the toxic range. This is a meaningful advantage: the drug reaches the infection site at high concentrations without exposing the kidneys and ears to the same level of risk that injectable gentamicin carries.
Severe and Life-Threatening Infections
When a dog develops sepsis, a systemic bacterial infection that can lead to shock and organ failure, gentamicin given by injection becomes a critical tool. It can be administered intravenously, intramuscularly, or subcutaneously. The recommended dose for dogs ranges from 9 to 14 mg/kg, typically given once daily in what’s called a single daily dose regimen. This dosing strategy maximizes the drug’s bacteria-killing power while giving the kidneys time to recover between doses.
In experimental sepsis research, dogs treated with intravenous gentamicin alongside a corticosteroid had dramatically better survival rates against lethal E. coli infections compared to untreated animals. This combination approach reflects how gentamicin is often used in practice: as part of a broader treatment plan for the most dangerous infections, not as a first-line antibiotic for routine problems.
Kidney and Hearing Risks
Gentamicin’s biggest drawback is its potential to damage two specific organs: the kidneys and the inner ear. These risks are dose-dependent and cumulative, meaning they increase with higher doses and longer treatment courses. Even low doses can cause harm, and the damage can continue to progress after the drug is stopped.
Kidney damage tends to appear first. Studies show measurable signs of kidney injury within the first seven days of treatment. The kidneys filter gentamicin out of the blood, and in the process, the drug accumulates in kidney cells and damages them. Early signs include changes in urine output, protein in the urine, and rising creatinine levels in the blood.
Hearing loss develops on a similar timeline but follows a different pattern. While kidney injury tends to peak and then partially recover, damage to the delicate hair cells in the inner ear is permanent and progressive. It typically begins with loss of high-frequency hearing and can worsen throughout and even after treatment. Because dogs can’t tell you they’re having trouble hearing, this damage often goes undetected until it’s significant.
For these reasons, vets who prescribe injectable gentamicin recommend daily monitoring of kidney function. This includes checking plasma creatinine levels, examining urine sediment for granular casts (tiny tube-shaped structures that indicate kidney cell damage), and tracking urine output. If any sign of toxicity appears, treatment is stopped immediately.
Medications That Increase Toxicity Risk
Several common veterinary drugs become dangerous when combined with gentamicin because they put additional stress on the kidneys. Your vet will avoid pairing gentamicin with:
- NSAIDs (common pain relievers and anti-inflammatories)
- Other aminoglycoside antibiotics
- Certain cephalosporin antibiotics
- Diuretics (medications that increase urine production)
- Cisplatin (a chemotherapy drug)
- Cyclosporine (an immune-suppressing drug)
If your dog is already taking any of these medications, a different antibiotic will likely be chosen. This is especially important for dogs with pre-existing kidney disease, where the kidneys are already compromised and far less able to tolerate gentamicin’s effects. In those cases, if gentamicin is absolutely necessary, the dose is adjusted downward and monitoring becomes even more frequent.
Why Gentamicin Is Reserved for Specific Situations
Gentamicin is not a go-to antibiotic for everyday infections. Its toxicity profile means vets reach for it when the bacteria involved are resistant to safer alternatives, when the infection is in a location that other antibiotics can’t reach effectively, or when the situation is urgent enough that gentamicin’s rapid killing power justifies the risk. Topical use in ears and eyes carries far less systemic risk than injections, which is why topical gentamicin prescriptions are relatively routine while injectable courses require careful planning and close follow-up.